Link Medicine Corporation

Biomatics Capital Partners closed its second fund focused on breakthrough science and technology in health care, bringing in $300m to fund the development of therapeutics, diagnostics, research and de

There have been plenty of casualties due to the consolidation and reorganization of the big pharmas as they try to concentrate on just a few therapeutic areas. This has meant the loss of jobs and plen

Biopharma companies closed 70 deals around the four major neurodegenerative diseases – Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Amyotrophic Lateral Sclerosis – in the period Jan

AstraZeneca PLC became the latest pharma to strike a deal with Vanderbilt University Medical Center to discover and develop neurology drug candidates, inking a two-year research deal with the un